University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent — Houston, Texas

University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent is a clinical research site located in Houston, Texas, United States 77030-4009.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent has participated in 1 clinical trials.

Therapeutic areas: Advanced Neuroendocrine Tumors of Pancreatic Origin.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent?

University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent conducted?

University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent has 1 clinical trials on record. Their work covers Advanced Neuroendocrine Tumors of Pancreatic Origin.

Is University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent accredited by Crixeo Health?

University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.